Wai Conrad
Wai Conrad, CEO, CH, reported an open-market or private sale at CLOVER HEALTH INVESTMENTS, CORP. DE involving 220426.000000 shares for an estimated $879499.74. Reported holdings after the transaction were 1390056.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- May 28, 2026
- Filing date
- May 28, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,610,482 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CLOV price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001971702-26-000010 Class A Common Stock
- Transaction date
- May 28, 2026 Filed May 28, 2026, 10:40 PM · 0d delay
- Shares
- 220,426 sh $3.99 per share
- Estimated value
- -$879k Computed from shares × price
- Holdings after
- 1,390,056 sh Indirect · By Trust.
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CEO, Counterpart Health
- F1
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is an average price. These shares…
- F2
Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
0 other transactions
0 recent txs